Mar 29, 2023 / 02:00PM GMT
Operator
Welcome to the CollPlant Biotechnologies investor conference call to discuss financial results for the full-year 2022 and corporate updates. The question-and-answer session will follow the formal presentation. (Operator Instructions) Now I'd like to turn the call over to Dory Kurowski of LifeSci Advisors. Please go ahead, ma'am.
Dory Kurowski - LifeSci Advisors, LLC - Director, Investor Communications
Good morning. I would like to welcome everyone to CollPlant Biotechnologies' first financial results conference call for the full year ended December 31, 2022. With us on the call today from CollPlant are Yehiel Tal, Chief Executive Officer, who will provide an overview of the company's programs and forthcoming updates; and Eran Rotem, Chief Financial Officer, who will provide a summary of CollPlant's financial results for the full year ending December 31, 2022.
Before we get started, I would like to remind everyone that statements made on this conference call may include forward-looking statements. Actual events or results could differ materially from
Q4 2022 Collplant Biotechnologies Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)